135 related articles for article (PubMed ID: 36321227)
1. The Determination of Molecular and Toxicological Mechanisms of Cucurbitacin E in Model Organism
Tunçbilek A; Azarkan SY; Ercan F
Curr Comput Aided Drug Des; 2023; 19(2):81-93. PubMed ID: 36321227
[TBL] [Abstract][Full Text] [Related]
2. The secondary metabolites produced by Lactobacillus plantarum downregulate BCL-2 and BUFFY genes on breast cancer cell line and model organism Drosophila melanogaster: molecular docking approach.
Sentürk M; Ercan F; Yalcin S
Cancer Chemother Pharmacol; 2020 Jan; 85(1):33-45. PubMed ID: 31673827
[TBL] [Abstract][Full Text] [Related]
3. The cucurbitacins D, E, and I from
Jafargholizadeh N; Zargar SJ; Aftabi Y
Iran J Basic Med Sci; 2018 Mar; 21(3):253-259. PubMed ID: 29511491
[TBL] [Abstract][Full Text] [Related]
4.
Ata FK; Ercan F; Azarkan SY
Curr Comput Aided Drug Des; 2022; 18(3):168-184. PubMed ID: 35538817
[TBL] [Abstract][Full Text] [Related]
5. Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
Escandell JM; Kaler P; Recio MC; Sasazuki T; Shirasawa S; Augenlicht L; Ríos JL; Klampfer L
Biochem Pharmacol; 2008 Jul; 76(2):198-207. PubMed ID: 18561895
[TBL] [Abstract][Full Text] [Related]
6. The plant-derived triterpenoid, cucurbitacin B, but not cucurbitacin E, inhibits the developmental transition associated with ecdysone biosynthesis in Drosophila melanogaster.
Toyofuku M; Fujinaga D; Inaba K; Funahashi T; Fujikawa Y; Inoue H; Kataoka H; Niwa R; Ono H
J Insect Physiol; 2021 Oct; 134():104294. PubMed ID: 34389412
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin B Activates Bitter-Sensing Gustatory Receptor Neurons via Gustatory Receptor 33a in
Rimal S; Sang J; Dhakal S; Lee Y
Mol Cells; 2020 Jun; 43(6):530-538. PubMed ID: 32451368
[TBL] [Abstract][Full Text] [Related]
8. Purification of Cucurbitacins D, E, and I from Ecballium Elaterium (L.) A. Rich Fruits and Study of Their Cytotoxic Effects on the AGS Cell Line.
Jafargholizadeh N; Zargar SJ; Yassa N; Tavakoli S
Asian Pac J Cancer Prev; 2016 Oct; 17(10):4631-4635. PubMed ID: 27892675
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induction through proteasome inhibitory activity of cucurbitacin D in human T-cell leukemia.
Ding N; Yamashita U; Matsuoka H; Sugiura T; Tsukada J; Noguchi J; Yoshida Y
Cancer; 2011 Jun; 117(12):2735-46. PubMed ID: 21656752
[TBL] [Abstract][Full Text] [Related]
10. Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B.
Yin S; Mai Z; Liu C; Xu L; Xia C
Phytomedicine; 2023 Mar; 111():154669. PubMed ID: 36681055
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.
Duangmano S; Dakeng S; Jiratchariyakul W; Suksamrarn A; Smith DR; Patmasiriwat P
Int J Mol Sci; 2010; 11(12):5323-38. PubMed ID: 21614210
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.
Dakeng S; Duangmano S; Jiratchariyakul W; U-Pratya Y; Bögler O; Patmasiriwat P
J Cell Biochem; 2012 Jan; 113(1):49-60. PubMed ID: 21866566
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways.
Mehdi Üremiş M; Üremiş N; Tosun E; Durhan M; Çiğremiş Y; Baysar A; Türköz Y
Curr Cancer Drug Targets; 2022; 22(11):931-944. PubMed ID: 35786188
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma.
Liu T; Zhang M; Zhang H; Sun C; Deng Y
Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1225-32. PubMed ID: 18309509
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.
Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P
BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of cucurbitacin-A in ovarian cancer cell line SKOV3 involves cell cycle arrest, apoptosis and inhibition of mTOR/PI3K/Akt signaling pathway.
Liu J; Liu X; Ma W; Kou W; Li C; Zhao J
J BUON; 2018; 23(1):124-128. PubMed ID: 29552771
[TBL] [Abstract][Full Text] [Related]
18. Potential of cucurbitacin as an anticancer drug.
Li Y; Li Y; Yao Y; Li H; Gao C; Sun C; Zhuang J
Biomed Pharmacother; 2023 Dec; 168():115707. PubMed ID: 37862969
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacins are insect steroid hormone antagonists acting at the ecdysteroid receptor.
Dinan L; Whiting P; Girault JP; Lafont R; Dhadialla TS; Cress DE; Mugat B; Antoniewski C; Lepesant JA
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):643-50. PubMed ID: 9581538
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line.
Üremiş N; Üremiş MM; Çiğremiş Y; Tosun E; Baysar A; Türköz Y
J Food Biochem; 2022 Oct; 46(10):e14333. PubMed ID: 35866877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
